Achieve Life Sciences Inc (ACHV) — Cash Flow-to-Debt Ratio
Achieve Life Sciences Inc (ACHV) has a Cash Flow-to-Debt Ratio of -0.89x as of December 2025, meaning its operating cash flow of $-17.98 Million could theoretically repay -1% of its total liabilities ($20.27 Million) in one year. See cash generation quality of Achieve Life Sciences Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Achieve Life Sciences Inc Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Achieve Life Sciences Inc across 32 annual periods. Also explore net asset momentum of Achieve Life Sciences Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Achieve Life Sciences Inc (1994–2025)
Year-by-year debt coverage analysis for Achieve Life Sciences Inc. For market capitalisation and broader financial context, see ACHV market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | $-49.47 Million | $20.27 Million | ▼ -45.4% |
| 2024 | -1.68x | $-29.77 Million | $17.73 Million | ▼ -42.8% |
| 2023 | -1.18x | $-24.48 Million | $20.82 Million | ▲ +32.2% |
| 2022 | -1.73x | $-37.57 Million | $21.67 Million | ▼ -14.7% |
| 2021 | -1.51x | $-29.44 Million | $19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | $-13.47 Million | $3.01 Million | ▲ +11.0% |
| 2019 | -5.03x | $-15.22 Million | $3.03 Million | ▼ -55.3% |
| 2018 | -3.24x | $-10.62 Million | $3.28 Million | ▲ +28.5% |
| 2017 | -4.52x | $-9.11 Million | $2.01 Million | ▼ -29.6% |
| 2016 | -3.49x | $-29.68 Million | $8.50 Million | ▼ -696.5% |
| 2015 | -0.44x | $-9.10 Million | $20.77 Million | ▲ +43.7% |
| 2014 | -0.78x | $-17.31 Million | $22.23 Million | ▲ +60.0% |
| 2013 | -1.94x | $-35.93 Million | $18.48 Million | ▲ +29.3% |
| 2012 | -2.75x | $-43.49 Million | $15.81 Million | ▼ -404.1% |
| 2011 | -0.55x | $-20.26 Million | $37.12 Million | ▲ +6.9% |
| 2010 | -0.59x | $-26.84 Million | $45.79 Million | ▼ -177.3% |
| 2009 | 0.76x | $34.88 Million | $46.02 Million | ▲ +125.1% |
| 2008 | -3.01x | $-12.31 Million | $4.08 Million | ▼ -72.4% |
| 2007 | -1.75x | $-23.34 Million | $13.34 Million | ▼ -126.1% |
| 2006 | -0.77x | $-19.68 Million | $25.45 Million | ▼ -109.5% |
| 2005 | -0.37x | $-8.36 Million | $22.65 Million | ▲ +91.2% |
| 2004 | -4.19x | $-14.62 Million | $3.49 Million | ▲ +8.8% |
| 2003 | -4.59x | $-9.91 Million | $2.16 Million | ▲ +2.4% |
| 2002 | -4.70x | $-10.40 Million | $2.21 Million | ▼ -551.4% |
| 2001 | 1.04x | $1.25 Million | $1.20 Million | ▲ +252.1% |
| 2000 | -0.69x | $-3.97 Million | $5.80 Million | ▼ -5449.7% |
| 1999 | -0.01x | $-100.00K | $8.10 Million | ▲ +98.6% |
| 1998 | -0.91x | $-10.30 Million | $11.30 Million | ▼ -777.1% |
| 1997 | 0.13x | $1.40 Million | $10.40 Million | ▼ -61.5% |
| 1996 | 0.35x | $3.50 Million | $10.00 Million | ▲ +139.0% |
| 1995 | -0.90x | $-7.80 Million | $8.70 Million | ▼ -212.5% |
| 1994 | -0.29x | $-3.50 Million | $12.20 Million | — |